4//SEC Filing
Janku Filip 4
Accession 0001209191-22-055037
CIK 0001826457other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:30 PM ET
Size
5.7 KB
Accession
0001209191-22-055037
Insider Transaction Report
Form 4
Janku Filip
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-10-31+36,000→ 36,000 totalExercise: $7.56Exp: 2032-10-02→ Common Stock (36,000 underlying)
Footnotes (2)
- [F1]On October 3, 2022, the Reporting Person was granted an option to purchase 36,000 shares of Common Stock, subject to the satisfaction of certain performance criteria. On October 31, 2022, the performance criteria underlying such shares were met.
- [F2]The shares underlying this option shall vest in full on April 30, 2024, subject to the Reporting Person's continued service on such date.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001862930
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 4:30 PM ET
- Size
- 5.7 KB